Agency for Medicinal Products and Medical Devices of the Republic of Slovenia
The joint HMA-EMA Network Data Steering Group (NDSG) is running an EU survey to inform research priorities for AI use in the development and evaluation of medicines. To access the […]
AI research priorities survey Read More »
The Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) will host a multi-stakeholder workshop on artificial intelligence (AI) on 20 and 21 November 2025. The workshop has
HMA / EMA multi-stakeholder workshop on artificial intelligence in medicines Read More »
As part of the Joint Action “Supporting the increased capacity and competence building of the EU medicines regulatory network” (IncreaseNET), funded under the EU4Health programme 2021–2027, the Italian Medicines Agency
call for expressions of interest Read More »
Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP), as the leader of Work Package 4 Sustainability within the EU4Health joint action Reinforced Market Surveillance of
Sustainability workshop of JAMS 2.0 outcomes Read More »
Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP) hosted members of the European Integrated Price Information Database (EURIPID) on May 13 and 14, 2025. The
Meeting of Members of the European Integrated Price Information Database (EURIPID) Read More »
Since February 2020, the EU Innovation Network (EU-IN) has been running a pilot project for simultaneous national scientific advice (SNSA) from national competent authorities (NCAs). SNSA specifically targets scenarios where
Since its launch on January 1, 2024, IncreaseNET has been dedicated to strengthening collaboration, knowledge-sharing, and training within the European Medicines Regulatory Network (EMRN). Over the past year, the project
IncreaseNET: A One-Year Progress Overview Read More »
